Cover Image

A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia

Abstract Background Patient affordability is an important nonclinical consideration for treatment access among patients with schizophrenia. Objective This study evaluated and measured out-of-pocket (OOP) costs for antipsychotics (APs) among Medicaid beneficiaries with schizophrenia. Methods Adults w...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dee Lin (Author), Dominic Pilon (Author), Laura Morrison (Author), Aditi Shah (Author), Marie-Hélène Lafeuille (Author), Patrick Lefebvre (Author), Carmela Benson (Author)
Format:	Book
Published:	Adis, Springer Healthcare, 2023-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with Schizophrenia
by: Zacker C, et al.
Published: (2024)

Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients
by: Siddhesh A Kamat, et al.
Published: (2015)

The Use Patterns of Medicaid Home and Community Based Services Among Medicare/Medicaid Beneficiaries With Dementia
by: Di Yan, et al.
Published: (2021)

Out-of-pocket and catastrophic expenses in households of patients with schizophrenia lacking social security
by: Hortensia Reyes-Morales, et al.
Published: (2021)

Patterns of health care use and out-of-pocket payments among general population and social security beneficiaries in Myanmar
by: Chaw-Yin Myint, et al.
Published: (2019)

Has Medicaid Managed Care Affected Beneficiary Access and Use?
by: Stephen Zuckerman, et al.
Published: (2002)

Provision of School-based Preventive Oral Health Services to Medicaid Beneficiaries
by: Anne R. Redmond, MPH, CHES, et al.
Published: (2005)

The Limited English Proficient Population: Describing Medicare, Medicaid, and Dual Beneficiaries
by: Kimberly Proctor, et al.
Published: (2018)

Addressing housing-related social needs for Medicaid beneficiaries: a qualitative assessment of Maryland's Medicaid §1115 waiver program
by: Robert DeGrazia, et al.
Published: (2023)

New atypical antipsychotics for schizophrenia: iloperidone
by: Silvio Caccia, et al.
Published: (2010)

Risk-based contracting for high-need Medicaid beneficiaries: The Arkansas PASSE program
by: Adrienne Nevola, et al.
Published: (2021)

The Effect of Consumer Incentives on Medicaid Beneficiaries' Compliance with Well-Child Visit Guidelines
by: John A. Nyman, et al.
Published: (2013)

Antipsychotics and Mortality in Adult and Geriatric Patients with Schizophrenia
by: Ling-Ling Yeh, et al.
Published: (2023)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
by: Norio Yasui‐Furukori, et al.
Published: (2020)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018)

Effects of the Families First Coronavirus Response Act on Coverage Continuity and Access for Medicaid Beneficiaries
by: Wei Lyu PhD, et al.
Published: (2024)

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
by: Charmi Patel, et al.
Published: (2019)

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
by: O'Day K, et al.
Published: (2013)

Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
by: Timothy Fitzgerald, et al.
Published: (2023)

A 3-State Analysis of Black-White Disparities in Diabetes Hospitalizations Among Medicaid Beneficiaries
by: William N. Mkanta, et al.
Published: (2018)

Does Managed Care Improve Access to Care for Medicaid Beneficiaries with Disabilities? A National Study
by: Teresa A. Coughlin, et al.
Published: (2008)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
by: Hülya Ertekin, et al.
Published: (2016)

Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia
by: Jaballah Fares, et al.
Published: (2023)

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
by: Lally J, et al.
Published: (2016)

The place of long-acting injectable antipsychotics in the treatment of schizophrenia
by: John M. Kane, et al.
Published: (2023)

Long-acting antipsychotic treatments: focus on women with schizophrenia
by: Sofia Brissos, et al.
Published: (2024)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018)

Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort Study
by: Charmi Patel, et al.
Published: (2023)

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
by: Boonlue T, et al.
Published: (2016)

Rural-urban differences in dental opioid prescribing among adolescent/young adult and adult Medicaid beneficiaries
by: Carla Shoff, et al.
Published: (2024)

Care Quality for Adult Medicaid Beneficiaries With Type 2 Diabetes Varies by Primary Care Provider Subspecialty
by: Robert Mayberry, et al.
Published: (2006)

Cognitive symptoms associated with antipsychotic course experience in residual schizophrenia
by: D. Safonov
Published: (2021)

Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication
by: Elnaz Faramarzi, et al.
Published: (2020)

Prescription of antipsychotics and prevalence of metabolic syndrome in Vietnamese inpatients with schizophrenia
by: Nguyen Thi Minh Thuan, et al.
Published: (2022)

Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia
by: Nina Vadiei, et al.
Published: (2022)

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
by: Xiaomei Peng, et al.
Published: (2011)

Equity in out-of-pocket payment in Chile
by: Alicia Lorena Núñez Mondaca, et al.

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
by: Timothy Fitzgerald, et al.
Published: (2023)

A comparative analysis of outcomes of root canal therapy for pediatric medicaid beneficiaries from New York State
by: Lorel E. Burns, et al.
Published: (2022)

Out-of-Pocket Costs for Facility-Based Obstetrical Care in Rural Guatemala
by: Michel Juarez, et al.
Published: (2021)